To study the contribution of v-Jun homodimers to oncogenesis, me const
ructed artificial v-Jun derivatives in which the natural dimerization
domain of v-Jun was replaced by an heterologous homodimerization domai
n from either the viral EB1 or the yeast GCN4 transcription factor. Th
e resulting v-Jun chimeric proteins, called v-Jun(eb1) and v-Jun(gcn4)
, which can no longer dimerize with Jun or Fos, should only form homod
imers in the cell. Helper-independent retroviruses expressing v-Jun, v
-Jun(eb1) and v-Jun(gcn4) were generated. AU three viruses transformed
primary cultures of chick embryo cells with the same high efficiency
and promoted local tumor growth after subcutaneous injection of infect
ed cells in young animals. In contrast, after intravenous injection of
viral suspensions into chick embryos, only the chimeric proteins prod
uced internal tumors that were lethal. These tumors were leiomyosarcom
as located within the liver and along the digestive tract. Thus, in vi
vo, v-Jun(eb1) and v-Jun(gcn4) are more potent oncoproteins than v-Jun
. These data demonstrate that when forced to accumulate, v-Jun homodim
ers can induce tumors efficiently. They also show that the oncogenic p
otential of v-Jun can be regulated through the properties of its dimer
ization domain.